Matches in Wikidata for { <http://www.wikidata.org/entity/Q90374475> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q90374475 description "article scientifique publié en 2018" @default.
- Q90374475 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q90374475 description "scientific article published on 20 July 2018" @default.
- Q90374475 description "wetenschappelijk artikel" @default.
- Q90374475 description "наукова стаття, опублікована в липні 2018" @default.
- Q90374475 name "Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital" @default.
- Q90374475 name "Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital" @default.
- Q90374475 type Item @default.
- Q90374475 label "Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital" @default.
- Q90374475 label "Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital" @default.
- Q90374475 prefLabel "Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital" @default.
- Q90374475 prefLabel "Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital" @default.
- Q90374475 P1433 Q90374475-313FDAE2-25DF-41EB-AB8E-E266127736D7 @default.
- Q90374475 P1476 Q90374475-61C27E1E-4081-4320-BBB8-62A26E9AEA80 @default.
- Q90374475 P2093 Q90374475-809BA772-A93D-4BC8-AC96-78DAADD17632 @default.
- Q90374475 P304 Q90374475-4AE7D0F5-8B38-46AF-971C-7C3535201ACD @default.
- Q90374475 P31 Q90374475-4A836647-EE42-430A-9191-A194991F85FC @default.
- Q90374475 P356 Q90374475-1AFDC80A-FC7A-4CFB-8721-10E1A9CA9C2F @default.
- Q90374475 P433 Q90374475-18E88FCD-AA53-424B-9CB8-5C3915FA9CFD @default.
- Q90374475 P478 Q90374475-9F5C0DAF-B3A5-48A2-8790-313116FB484C @default.
- Q90374475 P50 Q90374475-99041F9E-5A20-4557-9339-E19ADCCAC03D @default.
- Q90374475 P577 Q90374475-CBB9BE3C-BC5B-45BF-9D8B-59DE849828C5 @default.
- Q90374475 P698 Q90374475-8EEA9A54-107A-42B5-A0E0-797A5D32B40B @default.
- Q90374475 P921 Q90374475-6EB7C2E0-402A-4A64-89F8-A1EBF62D1BB8 @default.
- Q90374475 P921 Q90374475-938A566B-275F-4AAF-AE10-717FF4F3A658 @default.
- Q90374475 P356 SEXTRANS-2018-053698 @default.
- Q90374475 P698 30030303 @default.
- Q90374475 P1433 Q7458852 @default.
- Q90374475 P1476 "Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital" @default.
- Q90374475 P2093 "Hugh McGann" @default.
- Q90374475 P304 "420" @default.
- Q90374475 P31 Q13442814 @default.
- Q90374475 P356 "10.1136/SEXTRANS-2018-053698" @default.
- Q90374475 P433 "6" @default.
- Q90374475 P478 "94" @default.
- Q90374475 P50 Q80482341 @default.
- Q90374475 P577 "2018-07-20T00:00:00Z" @default.
- Q90374475 P698 "30030303" @default.
- Q90374475 P921 Q12204 @default.
- Q90374475 P921 Q937224 @default.